水蠻牛
冰火
關於保力達English
Company History About Us
Paolyta was founded in 1956, formerly known as Fu Hua Pharmaceutical Co., Ltd.; in 1960, to meet the business needs, after capital increase and reorganization the company was renamed as Paolyta Co., Ltd.. The founder, Mr. Chen, Chuan-Huang, in view of the importance of nutrition intake for the Taiwan people at the time, in 1968 financed the construction of a new plant with and area of more than 20,000 square meters in Hsingchuang, New Taipei City , and invited many domestic and foreign medical, chemical industry and nutrition experts to participate in the research and development of Paolyta B Liq. and a series of health foods, in the 60 years, the tireless efforts of all staff and consistent dedication to product quality have won the love and trust of the general public for our marketed products, from our initial capital of NT$ 300,000, after many capital increases, the current capital has reached NT$ 4.6 billion.
Complete Production Line
In 1988 the company invested heavily a new more than 40,000 square meters in the Hsinchu Industrial Park, which is also a GMP factory in line with national norms of good pharmaceutical --- the Hukou plant, producing Paolyta B Liq. series products, and in order to improve product quality, the Hukou plant has also obtained CGMP certification.
Currently because of operational considerations, production of Paolyta B has been transferred to the PIC/S GMP standard Chanda plant, and from Research and development, purchase of raw materials to the production process, all are under the careful monitoring of quality control and quality assurance, to ensure efficacy and safety of the medicinal products, and provide more protection to the interests of consumers.
Also, given the size of the beverage market demand, in 1996 our affiliated company has the Puli plant in Puli, Nantou County, renowned for the quality of its water, to mainly produce beverages; in 1998 we actively prepared to build the second Puli and Hukou Plants, mainly plan for a more complete product lineup. In the future, we expect to continue to innovate our business philosophy in the multiple fields of pharmaceutics, food and beverages, to continue to contribute to Taiwan people’s health.
In our future business plan, the company's development policy is:
Continue to build a diversified brand strategy
Follow the "Lateral enlarge to the products area, longitudinal enhancement of consumer interaction" principle, so the company's products, during the marketing and product development, are closer to modern, ever-changing consumer market trends, in order to create better sales performance and brand reputation.
1.Self-concept groups:
The Ice Fire sparkling wine series (lemon, grapes and champagne flavors) is well loved by office workers, housewives and young people; in 2015 the newly introduced Ice Fire cocktail BAR series added two new flavors: Mojito and Margarita, hoping to bring a new taste experience to Fire and Ice enthusiasts.
2.Sporty-concept group:
2.Sporty-concept group:
Based on consumer trends and commodity market research, nowadays consumers increasing emphasis on maintaining health, and sports and outdoor activities are hugely popular, so in 2012 the company launched a new "Nalyta Exercise Endurance Supply Beverages", with added new endurance element of D-ribose, 18 types of amino acid and other ingredients, also in 2015 launched the "Water Man-New Vitamin B Supply Beverages" both hydrating and refreshing, and we hope that through new demands and new concepts, the company can create a new niche.
3.Functional concept group:
Man-New Series Functional Drinks have always been the best choice for restoring strength and combat fatigue for manual laborers, drivers,modern office worker, night owls or heavy workers; in 2016 with the introduction of a new products, "Paolyta 99 Oyster Clam Essence", with the appeal of "Nourishing and strengthening the body", we provide consumers with more needs satisfaction and health supplies.
4.Health concept groups:The concept of health and longevity concept products is a modern consumer trend, and business opportunities in the biotechnology market are also becoming the mainstream battlefields, so the company R&D in of health concept-related items will also be continued.
Control consumption access trends, and actively develop the access market sales channels
With the market consumption trend moving toward health, vitality, and health care, the company’s overall marketing and market channel planning should be more actively using respond strategies, and ensure that the use of company resources and operating scale is more effective, increase the efficiency of customer service and shorten the distribution channel distance, thereby promoting fast response to meeting consumer desires for consumption, etc., will all be the focus of the company's ongoing work, this year the company, in addition to the existing sales channels, will also be developing and promoting the planning of more new channels.
Actively expand production facilities or outsourcing contracts, to reduce production costs, create product benefits
In recent years, in response to the increase in production output and products, the company has continued to expand the scale of the production line and has purchased new production equipment from abroad, in order to enhance quality and expand production capacity, so that the products, market and consumers can form a benign cycle and interaction, create better revenue and profits.
PIC/S GMP Production Management Production Control
In 2010 the Chanda plant obtained the PIC / S GMP certification, and the Paolyta B Liq. from product R & D, raw materials purchase to production process, has been subjected to rigorous quality control and quality assurance processes; the so-called "PIC/S GMP certification "is recognized worldwide as the most stringent pharmaceutical standard, to ensure the effectiveness of the drug quality and safety, and offer more protection to the interests of consumers.
